Magnetic resonance imaging and spectroscopy of the brain in HIV disease

Journal of HIV Therapy

Volumn 13, Issue 3, 2008, Pages 55-58

  Descamps, M J L ^a   Hyare, H ^a   Stebbing, J ^a   Winston, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DEOXYHEMOGLOBIN; DIDANOSINE; LAMIVUDINE; N ACETYLASPARTIC ACID; OXYHEMOGLOBIN; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BASAL GANGLION; BRAIN ATROPHY; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; COGNITIVE DEFECT; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOCHONDRIAL TOXICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPPORTUNISTIC INFECTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; VIRUS LOAD; VISUAL CORTEX; WHITE MATTER; AIDS DEMENTIA COMPLEX; BRAIN; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN; HIV INFECTIONS; HIV-1; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 70449681809     PISSN: 14620308     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology, 1991, 41, 778-785.
2. Dore GJ, Correll PK, Li Y et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 1999, 13, 1249-1253.
3. Tozzi V, Balestra P, Bellagamba R et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr, 2007, 45, 174-182.
4. Larussa D, Lorenzini P, Cingolani A et al. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses, 2006, 22, 386-392.
5. Schweinsburg BC, Taylor MJ, Alhassoon OM et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol, 2005, 11, 356-364.
6. Thurnher MM and Donovan Post MJ. Neuroimaging in the brain in HIV-1-infected patients. Neuroimaging Clin N Am, 2008, 18, 93-117, viii.
7. Kramer EL and Sanger JJ. Brain imaging in acquired immunodeficiency syndrome dementia complex. Semin Nucl Med, 1990, 20, 353-363.
8. Gelman BB and Guinto FC Jr. Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol, 1992, 32, 31-40.
9. Hawkins CP, McLaughlin JE, Kendall BE and McDonald WI. Pathological findings correlated with MRI in HIV infection. Neuroradiology, 1993, 35, 264-268.
10. Brew BJ, Rosenblum M, Cronin K and Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol, 1995, 38, 563-570.
11. Hall M, Whaley R, Robertson K et al. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology, 1996, 46, 1697-1702.
12. McArthur JC, Kumar AJ, Johnson DW et al. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr, 1990, 3, 252-259.
13. Paul R, Cohen R, Navia B and Tashima K. Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev, 2002, 26, 353-359.
14. Ross B, Kreis R and Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol, 1992, 14, 128-140.
15. Bottomley PA, Hart HR Jr, Edelstein WA et al. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology, 1984, 150, 441-446.
16. Laubenberger J, Haussinger D, Bayer S et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology, 1996, 199, 805-810.
17. Lopez-Villegas D, Lenkinski RE and Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA, 1997, 94, 9854-9859.
18. Salvan AM, Vion-Dury J, Confort-Gouny S et al. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol, 1997, 32, 485-495.
19. Jeremy RJ, Kim S, Nozyce M et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics, 2005, 115, 380-387.
20. Salvan AM, Lamoureux S, Michel G et al. Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res, 1998, 44, 755-762.
21. Banakar S, Thomas MA, Deveikis A et al. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children. J Magn Reson Imaging, 2008, 27, 710-717.
22. Owaga S, Lee TM, Nayak AS and Glynn P. Oxygenation sensitive contrast in magnetic resonance imaging of rodent brain at high magnetic fields. Magn Reson Med, 1990, 14, 68-78.
23. Kwong KK, Belleveau JW, Chester DA et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA, 1992, 89, 5675-5679.
24. Ernst T, Chang L, Jovicich J, Ames N and Arnold S. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology, 2002, 59, 1343-1349.
25. Thompson PM, Dutton RA, Hayashi KM et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci USA, 2005, 102, 15647-15652.
26. Castelo JM, Sherman SJ, Courtney MG, Melrose RJ and Stern CE. Altered hippocampal-prefrontal activation in HIV patients during episodic memory encoding. Neurology, 2006, 66, 1688-1695.
27. Melrose RJ, Tinaz S, Castelo JM, Courtney MG and Stern CE. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res, 2008, 188, 337-347.
28. Chang L, Yakupov R, Nakama H, Stokes B and Ernst T. Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients. J Neuroimmune Pharmacol, 2008, 3, 95-104.